NDC 68001-489

Abiraterone

Abiraterone Acetate

Abiraterone is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Bluepoint Laboratories. The primary component is Abiraterone Acetate.

Product ID68001-489_bb623af5-0efa-8964-e053-2a95a90a1440
NDC68001-489
Product TypeHuman Prescription Drug
Proprietary NameAbiraterone
Generic NameAbiraterone Acetate
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2021-02-26
Marketing CategoryANDA /
Application NumberANDA210686
Labeler NameBluePoint Laboratories
Substance NameABIRATERONE ACETATE
Active Ingredient Strength250 mg/1
Pharm ClassesCytochrome P450 17A1 Inhibitors [MoA],Cytochrome P450 17A1 Inhibitor [EPC],Cytochrome P450 2D6 Inhibitors [MoA],Cytochrome P450 2C8 Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 68001-489-07

120 TABLET in 1 BOTTLE (68001-489-07)
Marketing Start Date2021-02-26
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Abiraterone" or generic name "Abiraterone Acetate"

NDCBrand NameGeneric Name
0143-9597AbirateroneAbiraterone acetate
69539-049AbirateroneAbiraterone
72205-030AbirateroneAbiraterone
0093-1125Abiraterone AcetateAbiraterone Acetate
0378-6920Abiraterone Acetateabiraterone acetate
0378-6921Abiraterone Acetateabiraterone acetate
0378-6924Abiraterone Acetateabiraterone acetate
0904-6948Abiraterone AcetateAbiraterone Acetate
16714-963Abiraterone AcetateAbiraterone Acetate
42291-024Abiraterone AcetateAbiraterone
42291-073ABIRATERONE ACETATEABIRATERONE
42292-057Abiraterone Acetateabiraterone acetate
43598-358Abiraterone AcetateAbiraterone Acetate
47335-401YONSAabiraterone acetate

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.